Vialwirebiotech, curated
October 1, 2026, 12:36 AM
August 19, 2026
- 1:02 PM · STAT News
- 12:00 PM · BioWorld12:00 PMBD’s needle kits tied to four deaths in second major recall — BioWorld
- 12:00 PM · BioWorld12:00 PMOvid in $295M milestone deal for soticlestat; upside for Ligand — BioWorld
- 12:00 PM · BioWorld12:00 PMSnipr's anti-<em>E. coli</em> engineered phage positive in first patient — BioWorld
- 12:00 PM · BioWorld12:00 PMBiomarin seesaws on PPi axis, taking Alesta’s ALE-1 in $490M deal — BioWorld
- 12:00 PM · BioWorld12:00 PMOverton tapped for top job at the FDA — BioWorld
- 11:06 AM · Drug Discovery World11:06 AMMindMaze Therapeutics appoints strategic advisor for US growth — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMWith $33M series D, Craif takes urine cancer test platform to US — BioWorld
- 9:00 AM · BioWorld9:00 AMHarbour Biomed’s HBM-7004 cleared for clinic in China — BioWorld
- 6:45 AM · STAT News
- 5:04 AM · Pharmaceutical Technology5:04 AMAndelyn Biosciences to develop GM2 gangliosidosis therapy — Pharmaceutical Technology
- 4:30 AM · STAT News
- 3:49 AM · Pharmaceutical Technology3:49 AMBeOne Medicines and partners renew Brukinsa access programme for CLL — Pharmaceutical Technology
- 12:00 AM · FT — Pharmaceuticals12:00 AMBig pharma hunts for weight-loss drugs without nasty side effects — FT — Pharmaceuticals
August 18, 2026
- 5:14 PM · SCMP — Tech5:14 PMHarvard, MIT among 30 US universities ordered to audit China research ties — SCMP — Tech
- 12:00 PM · BioWorld12:00 PMGilead uses trademark as tool against non-FDA-approved imports — BioWorld
- 12:00 PM · BioWorld12:00 PMAvere tops private financings with $500M haul — BioWorld
- 12:00 PM · BioWorld12:00 PMQuestions rise on ivonescimab’s shrinking PFS in Harmoni-6 — BioWorld
- 11:00 AM · Drug Discovery World11:00 AMCalla Lily Clinical Care join Wellcome Leap’s antibiotics programme — Drug Discovery World
- 10:00 AM · Drug Discovery World10:00 AMCambrex builds new $30 million R&D facility — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMNIH SBIR grant supports Taxis’ FtsZ inhibitors for <em>C. difficile</em> — BioWorld
- 9:00 AM · BioWorld9:00 AMEvaxion discloses EVX-05 therapeutic glioblastoma vaccine — BioWorld
- 9:00 AM · BioWorld9:00 AMChugai grants GSK license for anti-dengue antibody AID-351 — BioWorld
- 9:00 AM · BioWorld9:00 AMFDA approves Amygdala Neurosciences’ IND for ANS-858 — BioWorld
- 8:59 AM · Drug Discovery World8:59 AMNucleai and Gilead Sciences enter oncology ADC collaboration — Drug Discovery World
- 8:00 AM · BioWorld8:00 AMCrystalo dermatology deal; Beone collaboration — BioWorld
- 8:00 AM · BioWorld8:00 AMLupin approval; Ocumension NDA — BioWorld
- 7:01 AM · STAT News7:01 AMSTAT+: Amylyx endocrine drug succeeds in pivotal study — STAT News
- 6:36 AM · PharmaVoice6:36 AMHow Helus’ new CEO plans to scale its psychedelic drug pipeline — PharmaVoice
- 6:29 AM · Pharmaceutical Technology6:29 AMUpdated UK guidance for finerenone introduces new treatment for HF patients — Pharmaceutical Technology
- 6:02 AM · Pharmaceutical Technology6:02 AMLEO outlays $435m for rights to Tanabe’s rare disease drug for sun-induced pain — Pharmaceutical Technology
- 6:00 AM · STAT News
- 5:09 AM · Pharmaceutical Technology5:09 AMFaeth’s PIKTOR plus paclitaxel combo gains FDA fast track status — Pharmaceutical Technology
- 3:56 AM · Pharmaceutical Technology3:56 AMFulcrum and Slate Medicines sign merger agreement — Pharmaceutical Technology